RPRX
NASDAQ · Pharmaceuticals
Royalty Pharma Plc- Cl A
$55.35
+1.78 (+3.32%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+41.13%
1Y
+53.15%
YTD
+42.43%
Open$53.58
Previous Close$53.57
Day High$55.50
Day Low$53.31
52W High$56.50
52W Low$34.08
Volume—
Avg Volume3.85M
Market Cap30.50B
P/E Ratio36.87
EPS$1.48
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$40.77
Above
SMA 200
$37.28
Above
RSI (14)
85.1
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
-34.5% upside
Current
$55.35
$55.35
Target
$36.26
$36.26
$26.65
$36.26 avg
$40.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.43B | 2.38B | 6.69B |
| Net Income | 786.54M | 693.60M | 946.13M |
| Profit Margin | 32.4% | 30.8% | 14.1% |
| EBITDA | 1.59B | 1.48B | 1.13B |
| Free Cash Flow | — | — | 700.09M |
| Rev Growth | +2.1% | +2.1% | +2.6% |
| Debt/Equity | 1.38 | 1.38 | 0.41 |
Dividend
Dividend Yield1.77%
Annual Dividend$0.65
Payout Ratio49.1%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |